Delivery Order SPE2DB20D7059-SPE2DB24FQHD4
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $30,556.20 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of M-M-R II vaccine vials and has a period of performance through April 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle to provide a comprehensive range of pharmaceutical products...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials to the U.S. government. The $1,537.17 firm-fixed-price delivery order was issued by the Department of Defense's (DoD) Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of June 27, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,707.76, is a delivery order for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of April 15, 2025 and is a firm fixed-price contract. No set-aside designation was used for this award. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,010.06 firm-fixed-price delivery order is for the supply of M-M-R II Vaccine Vials. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of M-M-R II vaccine vials, with a ceiling value of $2,561.90 and a completion date of July 3, 2024. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order under Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, which serves as the primary vehicle for the company to supply a range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,323.13 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a completion date of July 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025 with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,196.97 firm fixed price delivery order is for the supply of M-M-R II vaccine vials, with a period of performance through May 21, 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical to provide a wide range of pharmaceutical products...
This federal contract award was made by the Defense Logistics Agency (DLA) to the Corporate Office division of Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $9,557.28 firm fixed-price delivery order is for the supply of M-M-R II vaccine vials, with a performance period ending on June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025, which serves...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,626.57 firm-fixed-price delivery order is for M-M-R II vaccine vials, a critical immunization product. The contract has an ultimate completion date of December 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $2,706.51 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of M-M-R II vaccine vials and has a period of performance through March 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to...